Tumor Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Tumor stocks.

Tumor Stocks Recent News

Date Stock Title
Nov 22 GMED Reasons to Retain QIAGEN Stock in Your Portfolio for Now
Nov 21 NVCR Novocure secures FDA approval for add-ons to brain cancer treatment wearable
Nov 21 NVCR Novocure gets FDA approval for its HFE transducer arrays for glioblastoma treatment
Nov 21 GMED HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus
Nov 21 GMED ALGN Stock to Gain From CE Mark Win for Invisalign Palatal Expander
Nov 21 NVCR Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
Nov 21 NVCR FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
Nov 21 GMED GEHC Stock Likely to Gain on Portrait Mobile Solution's Prospects
Nov 20 GMED These 19 stocks are poised for tax reform turbocharge - Jefferies
Nov 20 GMED End Market Growth, New Acquisitions Drive Thermo Fisher's Shares
Nov 20 GMED Stryker Stock May Gain From Oculan Lighting Platform's Launch
Nov 20 GMED ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System
Nov 20 GMED ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio
Nov 19 GMED Patterson Companies Stock Up Following Latest Partnership Extension
Nov 19 GMED Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 View
Nov 19 GMED NVRO Stock Declines Despite Positive Study Data of Nevro1 System
Nov 19 GMED Reasons to Retain BSX Stock in Your Portfolio for Now
Nov 19 GMED BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX
Nov 19 GMED Boston Scientific Stock Set to Gain From Completion of Axonics Deal
Nov 18 GMED Globus Medical Stock: Re-Rated After A Solid Year
Tumor

A neoplasm is a type of abnormal and excessive growth, called neoplasia, of tissue. The growth of a neoplasm is uncoordinated with that of the normal surrounding tissue, and it persists growing abnormally, even if the original trigger is removed. This abnormal growth usually (but not always) forms a mass. When it forms a mass, it may be called a tumor.
ICD-10 classifies neoplasms into four main groups: benign neoplasms, in situ neoplasms, malignant neoplasms, and neoplasms of uncertain or unknown behavior. Malignant neoplasms are also simply known as cancers and are the focus of oncology.
Prior to the abnormal growth of tissue, as neoplasia, cells often undergo an abnormal pattern of growth, such as metaplasia or dysplasia. However, metaplasia or dysplasia does not always progress to neoplasia. The word is from Ancient Greek νέος- neo ("new") and πλάσμα plasma ("formation", "creation").

Browse All Tags